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Systemic lupus erythematosus (SLE) is a complex autoimmune disease. Genome-wide linkage studies implicated a region
containing the adhesion molecule P-Selectin. This family-based study revealed two regions of association within P-Selectin.
The strongest signal, from a 21.4-kb risk haplotype, stretched from the promoter into the first two consensus repeat (CR)
regions (P¼8 10
 4), with a second association from a 14.6-kb protective haplotype covering CR 2–9 (P¼0.0198). The risk
haplotype is tagged by the rare C allele of rs3753306, which disrupts the binding site of the trans-activating transcription factor
HNF-1. One other variant (rs3917687) on the risk haplotype was significant after permutation (P10000o1 10
 5), replicated in
independent pseudo case-control analysis and was significant by meta-analysis (P¼4.37 10
 6). A third associated variant on
the risk haplotype (rs3917657) replicated in 306 US SLE families and was significant in a joint UK-SLE data set after
permutation. The protective haplotype is tagged by rs6133 (a non-synonymous variant in CR8 (P¼9.00 10
 4), which also
shows association in the pseudo case-control analysis (P¼1.09 10
 3) and may contribute to another signal in P-Selectin. We
propose that polymorphism in the upstream region may reduce expression of P-Selectin, the mechanism by which this
promotes autoimmunity is unknown, although it may reduce the production of regulatory T cells.
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Introduction
Systemic lupus erythematosus (SLE) is a generalized
autoimmune disease that behaves as a complex genetic
trait. A number of groups have published genome-wide
and targeted linkage analyses.
1–5 There is considerable
heterogeneity within these linkage studies, no doubt
reflecting small study sizes, genetic heterogeneity and
clinical heterogeneity in SLE. The most consistently
mapped lupus susceptibility loci reside in the following
regions: 1q23, 1q25-31, 1q41-42, 2q35-37, 4p16-15.2, 6p11-
21 (MHC) and 16q12; all of which have been corro-
borated at least once in an independent cohort.
6,7 The
1q22-25 region, which contains SELP (P-Selectin), has
been identified as part of two genome-wide linkage
scans in humans.
3,4 The gene itself, alternately known as
P-Selectin, CD62 or Granulocyte membrane protein
(GMP140), is over 50kb long and contains 17 exons,
8
most of which encode discrete domain structures, as
described in the legend to Figure 1.
P-Selectin is a member of the selectin gene family,
which includes L-Selectin and E-Selectin. We have already
studied these two genes and found no evidence of
association with SLE, although two variants in the EGF
domain were associated with the levels of soluble
L-Selectin.
9 All three selectin genes are located in a gene
cluster on chromosome 1. The selectin molecules begin
with an N-terminal, ‘lectin’ domain followed by an ‘EGF’
domain, nine tandem consensus repeats similar to those
in complement-binding proteins, a transmembrane
domain and a cytoplasmic tail. SELP is longer than the
other selectin genes because it contains nine consensus
repeats (CRs) compared with six in E-Selectin and two in
L-Selectin.
10
We were interested in the role of P-Selectin as a
candidate gene for lupus because, in addition to the
linkage data, it also makes a good biological candidate
for a susceptibility gene. P-Selectin is primarily ex-
pressed on the cell membrane of platelets and endothe-
lial cells after cellular activation by molecules such as
histamine or thrombin, which cause release of the protein
from a-granules (platelets) or Weibel–Palade bodies
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11–14 The protein functions as an
adhesion molecule for a variety of leukocytes, including
neutrophils, monocytes, T cells, eosinophils, basophils,
platelets and some malignant cells,
15 thereby bringing to
sites of inflammation and into contact with a range of
cytokines and chemokines expressed by endothelial cells.
There are two receptors for P-Selectin, the major
leukocyte receptor, P-selectin glycoprotein ligand 1
(PSGL1), which is the high affinity receptor on both
myeloid cells and stimulated T lymphocytes,
16,17 and
CD24, which is expressed on a number of cells, including
B-lineage cells and T lymphocytes.
18 Furthermore, the 57
V allele of CD24 has also been recently described as a
susceptibility allele for lupus in a Spanish population
18
and for both multiple sclerosis
19 and rheumatoid
arthritis.
20
In addition to the genetic and biological reasons for
investigating the potential role for P-Selectin, there is
evidence from an animal model to support a role for the
gene in autoimmune glomerulonephritis. In this model,
P-Selectin-deficient mice show several defects in leuko-
cyte function, including almost absent leukocyte rolling in
mesenteric venules and delayed recruitment of neutrophils
to the peritoneal cavity after laboratory-induced inflamma-
tion using intra-peritoneal thioglycollate.
21
The work presented in this paper describes a compre-
hensive family-based association study to look for
potential susceptibility alleles, in a collection of UK and
US (Minnesota) SLE families.
Results
Selection of markers for analysis
Our genotyping strategy was to type the haplotype-
tagging single nucleotide polymorphisms (SNPs) across
SELP and also to include the synonymous/non-synon-
ymous coding variants in SELP, with minor allele
frequencies above 0.05 in Caucasian populations. We
therefore typed a total of 52 SNPs across the SELP locus
(Figure 1a). The final list of 29 markers used for
association analysis is shown in Table 4, following the
quality control checks described in the Materials and
methods.
TDT analysis for single SNPs
The results of the transmission disequilibrium test (TDT)
analysis using GENEHUNTER, in the UK SLE families
are presented in Table 1. These data show that there are
two association signals in SELP in two different regions
of the gene. The first significantly associated variant,
SNP 13 (rs3917687) is located in intron 1 (P¼8.00 10
–6)
and the second variant, SNP 36 (rs6133) is a non-
synonymous variation, in the CR region of the gene
Figure 1 Genomic organization and pattern of association across P-Selectin in UK SLE families. (a) Human P-Selectin consists of 17 exons.
The translated exons are illustrated as black boxes and the 50 and 30 UTRs as white boxes. The protein domains are shown as: E2 (S1)—
signaling domain 1; E3 (S2/Lec)—signaling domain 2/lectin-like domain; E4 (EGF)—epidermal growth factor-like domain; E5-13 (CR1-9)—
complement repeat regions; E14 (TM )—transmembrane domain; E15 (C1) cytoplasmic domain 1 and E16 (C2)—cytoplasmic domain 2. In the
diagram, the SNPs used in the analysis have been recoded as numbers from 1 to 52: SNP 1 (rs17523783), SNP 2 (A1969G)—identified by
sequencing of 60 UK SLE cases, SNP 3 (rs3753306), SNP 4 (rs3917651), SNP 6 (rs3917657), SNP 8 (rs3917862), SNP 10 (rs3917676), SNP 11
(rs3917682), SNP 12 (rs3917683), SNP 13 (rs3917687), SNP 14 (rs3917691), SNP 19 (rs6125), SNP 21 (rs6131), SNP 23 (rs2076074), SNP 24
(rs3917751), SNP 27 (rs2420378), SNP 28 (rs760694), SNP 29 (rs3917792), SNP 31 (rs2298903), SNP 33 (rs6127), SNP 34 (rs6132), SNP 36
(rs6133), SNP 41 (rs6136), SNP 42 (rs6128), SNP 43 (rs3917836), SNP 45 (rs3917848), SNP 48 (rs3753305), SNP 50 (rs6028) and SNP 52
(rs6703462) as listed in Table 4. The markers, which failed the quality control are place-marked in the sequence by gray lines. (b) The
haplotype block structure across SELP is constructed from 263 European Caucasian parent-proband trios from the UK study cohort. There is a
single haplotype block across the gene. The haplotypes are numbered on the left of each haplotype in brackets from 1–8 with the haplotype
frequencies shown to the right of each haplotype. Only haplotypes with a frequency of 42.5% are shown. The SNP numbers across the top of
the haplotypes correspond to those in the gene diagram. The haplotype bounded by a solid red line in block 1 shows over-transmission in the
UK SLE families and the haplotype inside the dashed blue box in block 2 shows under-transmission in the UK SLE families. The P-values for
the associated haplotypes are shown below their respective haplotype blocks. A full colour version of this figure is available at the Genes and
Immunity journal online.
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–4). After permutation analysis, using
10,000 permutations, both of these variants remain either
highly significantly (rs391687 P10000 o1 10
–5) or sig-
nificantly associated (rs6133 P10000¼3.30 10
 2). In our
UK families, there is no linkage disequilibrium (LD)
between these two variants (D0 ¼0.039, r
2¼0.001).
Haplotype structure across SELP in UK SLE families
We defined the boundaries of the haplotype blocks
across P-Selectin using Haploview (Figure 1b). There are
three haplotype blocks across the gene: block 1 stretching
21.4kb across the promoter, the signaling domains and
into the first three CR regions; block 2, which covers
14.6kb, stretching over most of the CR and block 3,
which is an 11.2-kb region including the transmembrane
domain and the 30 flanking region. Block 1 contains a
single risk haplotype, haplotype 5, which is tagged by
the C allele of SNP 3 (rs3753306). This haplotype 5 also
remains significantly associated after permutation ana-
lysis with 10000 permutations (P10000¼3.30 10
 2). All
the other haplotypes in block 1 carry one of the under-
transmitted minor alleles. The second region contains a
significant single SNP association is block 2. Haplotype
block 2 contains an under-transmitted haplotype, haplo-
type 11 (P¼0.0198). This protective haplotype is uniquely
tagged by the under-transmitted Tallele of SNP 36 (rs6133).
The breakdown in LD between blocks 1 and 2, as shown by
an inter-block D0 score of 0.21 (Figure 1b), provides further
indication that there may be multiple independent
association signals within P-Selectin.
Replication of the association signal for SELP in US
(Minnesota) SLE families
To seek replication of the UK association in SELP,w e
genotyped selected variants in an independent collection
of 306 Minnesota SLE parental-affected trios. We have
earlier used this population as a replication cohort for
our work on OX40L.
22 We used two strategies to confirm
that the Minnesota samples also made a suitable
replication cohort for P-Selectin. We tested for differences
in parental allele frequencies between the UK and
Minnesota populations (Supplementary Table 1) (P-value
40.05), and for differences in the pattern of LD across
the gene (data not shown). The results of the TDT
analysis for individual SNPs revealed associations in the
Minnesota samples with SNP 6 (rs3917657)
P¼3.70 10
 2,O R ¼0.627, 95% CI¼0.403–0.976) and
SNP 21 (rs6131) (P¼0.0219, OR¼0.732, 95% CI¼0.560–
0.957), presented in Table 1. The two over-transmitted
alleles of these two SNPs, the C allele of SNP 6 and the G
allele of SNP 21 (rs6133) are carried on the UK risk
haplotype.
Table 1 Analysis of Single SNPs across the P-Selectin by GENEHUNTER
SNP SNP Name Location MA UK SLE Trios (n¼263) MN SLE Trios (n¼306)
T:U w
2 P-value OR 95% CI T:U w
2 P-value OR 95% CI
1 rs17523783 Promoter T 69:69 0.0 1.0 1.0 0.716–1.40
2 A-1969G Promoter A 89:102 0.885 0.347 0.873 0.657–1.16
3 rs3753306 Promoter C 57:37 4.26 0.0391 1.54 1.02–2.33 68:56 1.16 0.281 1.21 0.830–1.73
4 rs3917651 Promoter A 25:34 1.37 0.241 0.735 0.439–1.23
6 rs3917657 I1 T 20:40 6.67 9.80 10
 3 0.500 0.292–0.855 32:51 4.35 0.037 0.627 0.403–0.976
8 rs3917862 I1 C 13:25 3.79 0.0516 0.520 0.266–1.02
10 rs3917676 I1 G 24:17 1.12 0.274 0.400 0.0776–2.06
11 rs3917682 I1 G 114:150 4.91 0.0267 0.760 0.596–0.970
12 rs3917683 I1 A 97:88 0.438 0.508 1.12 0.826–1.47
13 rs3917687 I1 C 12:46 19.9 8.02 10
 6 0.261 0.138–0.492
14 rs3917691 I1 T 93:88 0.138 0.710 1.06 0.790–1.41
19 rs6125 I4 A 24:34 1.72 0.189 0.706 0.419–1.19
21 rs6131 E 7 (CR3)* A 48:62 1.78 0.182 0.774 0.531–1.13 93:127 5.26 0.0219 0.732 0.560–0.957
23 rs2076074 I8 T 75:57 2.46 0.117 1.32 0.932–1.86
24 rs3917751 I8 T 78:56 3.61 0.0574 1.39 0.989–1.96
27 rs2420378 I8 T 128:106 2.07 0.150 1.21 0.934–1.56
28 rs760694 I10 C 97:105 0.317 0.574 0.924 0.701–1.22
29 rs3917792 I10 T 61:85 3.95 0.047 0.718 0.517–0.997
31 rs2298903 I10 T 85:73 0.911 0.340 1.16 0.852–1.59
33 rs6127 I10 C 117:106 0.543 0.461 1.10 0.849–1.44 141:139 0.0143 0.905 1.01 0.803–1.28
34 rs6132 E 11 (CR7)* T 50:71 3.65 0.0563 0.704 0.490–1.01 80:76 0.103 0.749 1.05 0.769–1.44
36 rs6133 E 12 (CR8)* T 28:59 11.0 9.00 10
 4 0.475 0.303–0.744 82:79 0.0559 0.813 1.04 0.762–1.41
41 rs6136 E 13 (CR9)* C 23:25 0.083 0.773 0.920 0.522–1.62 63:62 8.00 10
 3 0.929 1.02 0.716–1.44
42 rs6128 E14 A 63:81 2.25 0.134 0.778 0.560–1.08
43 rs3917836 I14 G 32:39 0.69 0.406 0.821 0.514–1.31
45 rs3917848 I15 G 13:20 1.49 0.223 0.650 0.323–1.31
48 rs3753305 E17 C 128:121 0.197 0.657 1.06 0.825–1.36
50 rs6028 E17 C 65:66 8.00 10
 3 0.930 0.985 0.699–1.39
52 rs6703462 E17 T 30:36 0.545 0.460 0.833 0.513–1.35
Abbreviations: CI, confidence interval; MA, minor allele for each variant; OR, odds ratio; MN SLE, Minnesota systemic lupus erythematosus;
SNP, single nucleotide polymorphism; T:U, transmission: untransmission ratio of the minor allele: major allele.
TDTanalysis by GENEHUNTER for each SNP tested in the 263 UK SLE families, and 306 US Minnesota families showing the location of each
analyzed SNP within the gene. Those SNPs marked with an asterisk are either non-synonymous (rs6131—Asn/Ser, rs6133—Leu/Val and
rs6136—Pro/Thr) or synonymous (rs6132—Asn/Asn). ‘SNP analyzed’, gives the order of analyzed SNPs. For each variant w
2 is listed and the
P-value is quoted with one degree of freedom, together with the OR and the 95% confidence intervals.
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Genes and ImmunityJoint analysis in UK and US (Minnesota) SLE families
We wanted to carry out a joint UK–US analysis across
P-Selectin. Tests for stratification were carried out on the
assumption that the two populations were indeed
homogenous across P-Selectin: when employing Pear-
son’s w
2-test, we did not reject this assumption with
respect to the transmission ratios (P40.001) (Supple-
mentary Table 2) and using the Breslow–Day test, we did
not reject the assumption with respect to the odds ratios
(P40.001) (Supplementary Table 3). All of these factors
give us the confidence to do a robust joint analysis
between the two populations. The results of this joint
analysis, presented in Table 2, show a stronger associa-
tion for SNP 3 (rs3753306), SNP 6 (rs3917657) and SNP 21
(rs6131) in the joint UK–US data set, compared with
either of the two independent UK or US data sets. The
risk alleles of all the three variants are carried on the risk
haplotype defined in the UK SLE families (Figure 1b).
Furthermore, the association with SNP 6 remains sign-
ficant after permutation analysis with 10000 permuta-
tions (P¼7.20 10
 3). Haplotype–TDT analysis in the
joint data set adds further evidence to the over-
transmission of a SNP 3(C)-SNP 6(C)-SNP 21(G) haplo-
type (P¼0.0239). These are alleles all carried on the
more-densely mapped UK SLE risk haplotype. An
under-transmitted T-T-A haplotype was also seen in
the combined data set. This haplotype: SNP 3(T)-SNP
6(T)-SNP 21(A) haplotype (P¼3.10 10
 3) is carried on
UK SLE haplotypes 6 and 7, both of which show a trend
for under-transmission (Po0.05). These data serve to
confirm the importance of the promoter region of
P-Selectin in the association signal.
Replication using pseudo case-control analysis
with imputed genotypes
To extend our analysis, we used imputation to test un-
genotyped variants within the chromosomal ranges of
our existing UK genotyping. We then sought to replicate
the associations observed in our UK trio collection by
carrying out an imputation-based ‘pseudo case-control’
analysis with a set of 270 cases independent from the 263
UK SLE families used for our TDT association study.
Figure 2a shows a plot of –log (P-value) for all the SNPs
used in the pseudo case-control association study against
chromosomal position. The P-values for the variants
with the strongest association are presented in Table 3.
These data reveal independent replications of the
association seen by TDT analysis in our UK families for
two variants within the bounds of the upstream risk
haplotype: SNP 12 (rs3917683) (P-value¼0.0270) and
SNP 13 (rs3917687) (P-value¼0.0330), with a third
borderline association for SNP 21 (rs6131) (P-
value¼0.053), which also lies on the risk haplotype. It
is interesting that when we repeated the imputation on
taking both the 263 cases from the trios and the
additional 270 independent cases and then re-did the
pseudo case-control analysis, there was highly signifi-
cant association for SNP 13 rs3918687 (P¼2.52 10
–5)
and a significant association for non-synonymous variant
SNP 36 (rs6133) (P¼1.09 10
 3). The imputed SNPs in
the independent cases data were not significant, whereas
several SNPs showed marginal levels of significance in
the combined data set (Figure 2b).
Meta-analysis
To maximize the numbers of samples for the association
analysis, we combined the P-values for SNPs on the UK
risk haplotype, which showed association (SNP 13—
rs3917687 and SNP 12—rs3917683) or a trend for
association (SNP 21—rs6131) in the pseudo case-control
analysis and/or showed association in either the 263 UK
parental-proband trios (rs3917687) or the 306 Minnesota
trios (rs6131) and in the imputation analysis. These
results revealed a highly significant P-value for SNP 13
(P¼4.37 10
–6) and a significant association for SNP 21
(P¼9.56 10
 3).
Discussion
P-Selectin is located in the SLE linkage region on human
chromosome 1 (1q23). Linkage studies in humans and in
animal models of lupus have suggested an important
role for the gene in SLE. The current family-based
Table 2 Permutation analysis of single SNPs across P-Selectin in a UK and US (Minnesota) SLE families
rs Study rs3753306
(SNP 3)
rs3917657
(SNP 6)
rs6131
(SNP 21)
rs6127
(SNP 33)
rs6132
(SNP 34)
rs6133
(SNP 36)
rs6136
(SNP 41)
T:U UK 57:37 20:40 48:62 117:106 50:71 28:59 23:25
MN 68:56 32:51 93:127 141:139 80:76 82:79 63:62
Joint 125:93 52:91 141:189 258:245 130:147 110:138 86:87
OR (CI) UK 1.5 (1.0–2.3) 0.50 (0.29–0.86) 0.77 (0.53–1.1) 1.1 (0.85–1.4) 0.70 (0.49–1.0) 0.48 (0.30–0.74) 0.92(0.52–1.6)
MN 1.2 (0.83–1.7) 0.63 (0.40–0.98) 0.73 (0.56–0.96) 1.0 (0.80–1.3) 1.1 (0.77–1.4) 1.0 (0.76–1.4) 1.0 (0.72–1.4)
Joint 1.3 (1.03–1.76) 0.57 (0.41–0.80) 0.75 (0.60–0.93) 1.1 (0.88–0.70) 0.88 (0.70–1.1) 0.78 (0.62–1.0) 0.99 (0.73–1.3)
P (P10000) UK 0.039 (0.68) 0.0099 (0.264) 0.18 (0.99) 0.46 (1.0) 0.056 (0.79) 9.04 10
 4 (0.025) 0.77 (1.0)
MN 0.28 (0.86) 0.037 (0.12) 0.022 (0.12) 0.91 (1.0) 0.75 (1.0) 0.82 (0.99) 0.93 (1.0)
Joint 0.029 (0.18) 0.0016 (0.0072) 0.014 (0.054) 0.61 (0.99) 0.30 (0.90) 0.081 (0.38) 0.97 (1.0)
Abbreviations: CI, confidence interval; MN, Minnesota; OR, odds ratio; SLE, systemic lupus erythematosus; SNP, single nucleotide
polymorphism; T:U, transmission: untransmission ratio of the minor allele: major allele.
A comparison of the permutation analyses for single SNPs across SELP in 263 UK SLE trios (UK), 306 US SLE trios (MN) and a joint dataset
(joint). Each SNP was analyzed independently in each dataset and the transmission:untransmission ratios (T:U) are shown, together with the
odds ratio and 95% confidence intervals OR (CI) and the P-value and P- value after 10,000 permutations P(P10000). The SNP in bold, rs391657
retains significance after permutation analysis.
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Genes and Immunityassociation testing of this candidate gene has provided
significant evidence for the association to SLE in two
independent populations. Specifically, we are confident
that we have discovered a risk haplotype stretching
across the promoter of P-Selectin, and we have additional
evidence to support a second signal in the CR region of
the gene.
This is the first report of an association for P-Selectin in
the upstream region of the gene. In our 263 UK SLE
families, a single risk haplotype, haplotype 5, is
responsible for the signal from the upstream region of
SELP—haplotype block 1 in Figure 1b. This haplotype
remains significant following permutation analysis
(P10000¼0.0330). There are no other haplotypes in this
region, which show association. The presence of this
single associated haplotype in block 1 may be because of
the pattern of association for the associated SNPs within
the block, namely the allele frequencies of the over-
transmitted alleles. In this respect, SNP 3 (rs3753306) is
unique, in that it has an over-transmitted rare allele
carried on the risk haplotype. For all the remaining
associated polymorphisms in this region, SNPs 6, 8, 11
and 13, it is the common allele, which is the risk allele.
The higher frequency of these major risk alleles means
that they are present on multiple different haplotypes. In
these situations, pinpointing the ‘etiological haplotype’
will require a greater density of typing to allow
discovery of possible recombination events. However,
we believe that there are associated variants in the
upstream region of P-Selectin because we have replicated
the association for two alleles, which are carried on the
risk haplotype (SNPs 6 and 21) in the Minnesota SLE
families. Furthermore, we then went on to not only show
that the association for SNP 6 is stronger in the joint UK–
US data set compared with the individual populations,
but that the association is still significant following
permutation analysis (P10000¼7.20 10
 3) (Table 2).
To determine whether we could localize the causal
alleles for association to the upstream region of P-Selectin,
we carried out imputation analysis for variants across
P-Selectin in an independent collection of 270 UK SLE
cases. The strongest result was the independent replica-
tion of SNP 13 (rs3917687) (P¼0.0339) (Table 3). We
confirmed that it was the same (C) allele of this variant
that was both under-represented in SLE cases (Table 3)
and under-transmitted in the 263 UK trios (Table 1). The
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Figure 2 Results of pseudo case-control analysis with imputation. (a) Pseudo case-control analysis using the 270 independent cases and
pseudo controls. (b) Pseudo case-control analysis using both the 270 independent cases and the 263 cases from the UK SLE trios. For both
these analyses the imputation was carried out on only the un-genotyped SNPs. The circles containing stars (*) signify the results for SNPs
included in the original genotyping, whereas the empty circles signify the results for SNPs, which were only part of the imputation study.
Table 3 Results of pseudo case-control and meta-analysis
SNP SNP name P values for association
c Case-control analysis (n¼270) UK SLE trios (n¼263) MN SLE trios (n¼306) Fisher’s test
12 rs3917683 0.0275 0.508 — 0.0736
13 rs3917687 0.0339 8.03 10
 6 — 4.37 10
 6
21 rs6131 0.0523 0.182 0.0219 0.00956
Abbreviations: MN, Minnesota; SLE, systemic lupus erythematosus; SNP, single nucleotide polymorphism.
The P-values are quoted with 1df for the pseudo case-control analysis in UK SLE samples, UK SLE trios, MN SLE trios. The column marked
‘Fisher’s Test’ represents the P-value from the meta-analysis, using the studies indicated.
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was further strengthened by the finding that the same
variant, SNP 13, was highly significantly associated
following pseudo case-control analysis, using both the
cases from the 263 trios and the 270 independent UK cases
(Figure 2b) (P¼2.52 10
–5). Furthermore, we have also
s h o w nt h a tt h ea s s o c i a t i o nf r o mS N P1 3r e m a i n e dh i g h l y
significant following permutation analysis in our 263 UK
trios (P10000 o1 10
–5).
Having established that variants in the upstream
region of P-Selectin may contribute to disease suscept-
ibility, we went on to look for the potential functional
significance for any of the associated SNPs on the risk
haplotype. We discovered that the risk C allele of
rs3753306 disrupts the binding site for the HNF-1, a
trans-activating transcription factor, expression of which
is predominantly restricted to the liver and kidney. It is
possible that this loss-of-function risk allele in the
promoter may reduce production of P-Selectin, thereby
reducing recruitment of pro-inflammatory leukocytes.
However, in a mouse model, loss of P-Selectin in MRLfas
mice by a gene-targeted deletion leads to increased
glomerulonephritis.
23 In another mouse model of glo-
merulonephritis, P-Selectin-deficient mice show
increased proteinuria, glomerular damage and mortal-
ity.
24 However, although these animal models have the
potential to provide a link between decreased production
of P-Selectin and increased risk of renal disease, there
may be a complication in the interpretation the results.
This complication was first identified by Bygrave et al.,
who discovered that the 129-derived chromosome 1
segment used for gene-targeted deletions may itself
produce symptoms of autoimmunity. Therefore, the
observed increase in renal disease noted in the
‘P-Selectin-deficient’ mice may be the result of the effect
of a 129-derived chromosome 1 segment rather than a
primary effect from P-Selectin deficiency.
25 However, in
human renal disease, a reduction of P-Selectin transcrip-
tion has been reported. No P-Selectin mRNA transcript
was detected in the glomerulus of renal cases, despite an
increased expression of glomerular P-Selectin.
26 The
increase in protein expression may reflect the release of
stored P-Selectin from storage granules rather than
increased gene expression, as P-Selectin is constitutively
produced in the secretory granules of platelets
(a-granules) and endothelial cells (Weibel–Palade
bodies), but is not expressed on the cell surface until an
appropriate stimulus is provided.
14
Given the evidence presented above, it is intriguing to
hypothesize that variants in P-Selectin may have a role in
renal lupus, but we do not have sufficient power within
the UK SLE cohort used for this paper to assess whether
the association in P-Selectin is stronger for UK SLE
families in which the affected offspring has renal disease.
An alternative functional consequence of a reduced
expression of P-Selectin is a potential reduction in the
numbers of regulatory T cells. A recent publication by
Urzainqui et al.
27 reported that the engagement of
P-Selectin ligand on dendritic cells with P-Selectin may
increase the production ability of the dendritic cells to
generate CD4þ CD25þ Foxp3þ regulatory Tcells. This
reduction in the production of regulatory T cells may in
turn lead to increased incidence of autoimmune disease.
However, SNP 3 (rs3753306) is not the only suscept-
ibility allele in the upstream region of P-Selectin because
although this variant is located o1kb upstream from the
50 UTR, it is carried on a risk haplotype stretching into
the CR regions. There are several other protein domains
within the bounds of this haplotype, which may
contribute to disease pathogenesis. The region between
SNP 3 and SNP 6 (found o1kb downstream of the
50 UTR) contains the proximal promoter, a 249-bp section
of upstream sequence, which has been shown to promote
a high level of gene expression in cultured endothelial
cells.
28 The risk haplotype also includes the lectin and
EGF domains, which are necessary for P-Selectin to bind
to its ligand PSGL.
29,30 Changes in the affinity of the
binding between P-Selectin and its ligand will affect the
recruitment of leukocytes to the sites of inflammation.
Although the two SNPs we typed in these domains failed
the quality control, it is probable that there are other
unknown variants, which may be important in disease
etiology. All these data would suggest that either SNP 3,
SNP 6 and/or another variant(s) in LD with them play
an important role in increasing the risk of SLE. Never-
theless, to identify the exact causal variants in P-Selectin,
it will be necessary to undertake extensive re-sequencing
of the 21.4-kb risk haplotype.
Establishing a convincing association within the CR
region of the gene proved to be more challenging. As
there were many variants in the coding region of the
gene, around the nine CR it was an attractive hypothesis
to believe that the core association came from these
sequences. However, as shown in Table 4, many of these
variants failed to generate reliable assays or were of low
minor allele frequency. This may be because of the high
level of sequence similarity between the separate CRs,
which affect genotyping efficiency. Although our study is
the first to report an association for P-Selectin arising
from the upstream region of the gene, there has been one
earlier report of an association in SELP with lupus from
an SNP in the coding region.
31 The variant in question, is
SNP 38 (rs3917815) a Ser/Asn non-synonymous poly-
morphism located in E12. We genotyped SNP 38 as part
of our current study, but the variant proved to be
monomorphic, and therefore was excluded from our
analyses. These data agree with the genotype data on the
CEU samples from the HAPMAP database. Neverthe-
less, in the same exon in the SNP described by Jacob, we
find significant association from a Leu/Val non-synon-
ymous variant in CR 8 (SNP 36—rs6133). The associated
allele was the under-transmitted allele T (Val) allele,
which tags the protective haplotype. We went on to show
that the association from rs6133 remains significant
after permutation analysis in our 263 UK families
P10000¼0.0250 (Table 2). The consensus repeat domains
are thought to be important, but not essential, in binding
P-Selectin to its ligand on leukocytes. It is possible that
the over-transmitted G (Leu) allele of SNP 36 results in a
stronger ligand binding, and if so, may contribute to an
increase in inflammatory activity, resulting from greater
recruitment of leukocytes to sites of inflammation. We
also know that the same G (Leu) allele of this variant has
earlier been reported as being associated with throm-
boembolic stroke
32 and atopy.
33 As in our UK SLE
families, the T allele of SNP 36 (rs6133) is unique to the
under-transmitted haplotype in block 2 (Figure 1b) and
we observed no LD with the risk haplotype in block 1,
we think that rs6133 may tag a second signal within
P-Selectin.
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Details of study cohorts
The collection of the UK Caucasian SLE families
consisted of a total of 263 complete trios and 270
independent UK families. All probands conformed to
the American College of Rheumatology criteria for SLE,
34
with a diagnosis of SLE being established by telephone
interview, health questionnaire and details from
clinical notes. Written consent was obtained from
all participants, including relatives. In the United
Kingdom, ethical approval was obtained from
Multi-Centre Research Ethics Committee. Genomic
DNA from the UK samples was isolated from
Table 4 Markers selected for genotyping across P-Selectin
SNP SNP name Location Function Position MAF Alleles Analysed
1 rs17523783 Promoter 167868865 0.293 G4TY
2 A1969G Promoter 167867905 0.401 G4AY
3 rs3753306 Promoter 167866856 0.113 T4CY
4 rs3917651 Promoter 167866686 0.065 G4AY
5 rs3917652 Promoter 167866686 Mono A¼A Mono
6 rs3917657 I1 167865366 0.074 C4TY
7 rs2236866 I1 167862937 NA A/T Failed
8 rs3917862 I1 167859737 0.057 T4CY
9 rs2236867 I1 167859611 0.053 T4GH W E
10 rs3917676 I1 167859135 0.05 T4GY
11 rs3917682 I1 167858172 0.381 T4GY
12 rs3917683 I1 167857997 0.427 G4AY
13 rs3917687 I1 167857717 0.101 T4CY
14 rs3917691 I1 167857418 0.239 C4TY
15 rs2244526 I2 167853570 0.184 A4GH W E
16 rs7529463 E3 His/Arg 167853201 0 C¼C Mono
17 rs6129 E3 Pro/Pro 167852954 0.008 G4AM A F
18 rs3917718 E4 Arg/Gly 167849502 0.004 G4AM A F
19 rs6125 E5 Met/Val 167848941 0.062 G4AY
20 rs3917724 E6 Ile/Thr 167848219 0 C4CM A F
21 rs6131 E7 Asn/Ser 167847509 0.158 G4AY
22 rs6134 E7 Met/Val 167847408 0 A¼A Mono
23 rs2076074 I8 167845210 0.21 C4TY
24 rs3917751 I8 167843192 0.338 C4TY
25 rs6130 E9 Phe/Ser 167842831 0 C¼C Mono
26 rs2205895 I9 167839269 0.32 G4AG T
27 rs2420378 I10 167836542 0.336 A4TY
28 rs760694 I10 167835322 0.463 A4CY
29 rs3917792 I10 167834456 0.221 G4TY
30 rs3917793 I10 167834169 0.097 G4TG T
31 rs2298903 I10 167834140 0.301 A4TY
32 rs6135 E11 Cys/Cys 167832950 0 C4CM A F
33 rs6127 E11 Asn/Asp 167832937 0.433 A4GY
34 rs6132 E11 Asn/Asn 167832932 0.133 C4TY
35 rs3917812 I11 167831996 G¼G Mono
36 rs6133 E12 Leu/Val 167831970 0.139 G4TY
37 rs3917814 E12 Asn/Thr 167831906 0 C¼C Mono
38 rs3917815 E12 Ser/Asn 167831880 0 A¼A Mono
39 rs3917818 I12 167831542 0 C¼C Mono
40 rs1569471 I12 167830754 0.209 A4CH W E
41 rs6136 E13 Pro/Thr 167830575 0.09 A4CY
42 rs6128 E14 Thr/Thr 167829528 0.16 G4AY
43 rs3917836 I14 167827898 0.095 A4GY
44 rs3917848 I15 167826415 0 C¼C Mono
45 rs3917848 I16 167826415 0.074 T4GY
46 rs3917855 30 flank 167825497 0 C4C Mono
47 rs1018828 30 flank 167824358 0.104 T4GG T
48 rs3753305 30 flank 167820682 0.469 G4CY
49 rs9332683 30 flank 167820013 0.015 T4CM A F
50 rs6028 30 flank 167818306 0.273 T4CY
51 rs9332684 30 flank 167818159 0.027 A4GM A F
52 rs6703462 30 flank 167817214 0.106 G4TY
Abbreviation: HWE, Hardy–Weinberg.
The position of the markers is shown in bp on the Nov 2008 build of HAPMAP. The column marked ‘Location’ gives the position of the
variant within the gene and the column marked ‘Function’ indicates which SNPs are coding variants. The column marked ‘MAF’ gives the
minor allele frequency for the UK parental samples and the column marked ‘Alleles’ shows the major4minor alleles for each variant. The last
column, labeled ‘Variants for Analysis’ shows the SNPs, which were included in the association analyses (marked Y) and categorizes the
reasons for exclusion of the remaining SNPs: MAF, minor allele frequency o5%, HWE, Po0.001, GT, GT o75% and failed, SNP failed to
generate a viable assay.
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chloroform extraction.
Non-UK family collection for corroborative genotyping
Corroboration of the UK association study in SELP was
investigated using a total of 306 US parental-affected
trios, taken from the Minnesota SLE collection. These
studies were approved by the Human Subject Institu-
tional Review Boards at the University of Minnesota, and
informed consent was obtained from all the patients.
Selection of markers
In this study a total of 52 markers were selected from
across P-Selectin, taken from the public databases, dbSNP
(http://www.ncbi.nlm.nih.gov/SNP/index.html) and
from HAPMAP (http://www.hapmap.org/). A single
SNP (A1969G) was identified by re-sequencing 60 UK
SLE probands. Preliminary genotyping was carried out
in 263 UK trios, with markers being excluded from the
analysis if they showed a genotyping success of o75%,
had 45% of families with Mendelian errors as identified
by PEDCHECK and/or had a Hardy–Weinberg P-value
in the parental samples of oP¼0.001 (Table 4). Three
markers were removed because of low genotyping
frequency, ten markers were monomorphic, six markers
had low minor allele frequency and three other markers
that were removed had a Hardy–Weinberg (HWE)
P-value of o0.001 in the founder chromosomes. A
further marker failed to generate a viable assay with
Sequenom methodology. In the Minnesota samples, we
sought replication for several of the variants from our
UK families. None of the seven markers typed in the
Minnesota samples failed the quality control.
Genotyping methodology
The genotyping in the UK samples was carried out using
MALDI-TOF mass spectrometry (Sequenom, San Diego,
CA, USA)
35 and analysis of the raw genotype data was
carried out using the MassArray Typer v3.4 software
(Sequenom). After visual inspection of the clusters,
manual adjustments were made for some of the assays
by the Sequenom iPlex system (Sequenom, San Diego,
CA, USA).
Statistical analysis
All sample genotype and phenotype data were managed
by, and analysis files were generated with BC/SNPmax
and BC/CLIN software (Biocomputing Platforms Ltd,
Espoo, Finland). A comparison of the parental allele
frequencies between the UK and US collections was
made using w
2 analysis in a 2 2 contingency table, with
the level of significance being presented as a P-value
with 1 d.f. Pearson’s test was used to compare the ratio of
transmitted to untransmitted (T:U) families for each
marker and the Breslow–Day test in PLINK was used to
test homogeneity of odds ratios between the two
populations.
Association of alleles to SLE for both individual and
multiple SNPs was tested by the TDT, which compares
the observed and expected transmission of alleles from
heterozygous parents with affected offspring. This
analysis was carried out using PLINK (http:/ /pngu.
mgh.harvard.edu/~purcell/plink/).
Haplotype–TDT was carried out using Haploview. For
SNPs in each gene, haplotype patterns were generated
using haplotype block definitions on the basis of the
solid-spine algorithm, described on the Haploview
website, with an LD cut-off at D0 ¼0.6. This program
constructs haplotypes on the basis of the D0 measure of
LD,
36 together with a logarithm of the odds (LOD) score
as measure of significance and 95% confidence intervals
to state the accuracy of the P-value. The pairwise linkage
LD for SNPs across each gene was confirmed by the r
2
values.
37,38 Only markers having minor allele frequency
of 45% were included in the haplotype constructions
and haplotypes with a frequency of 43.0% were
included in the LD diagrams.
Imputation analysis
Imputation was carried out on the cases and pseudo-
controls using IMPUTE, by the method described by
Marchini et al.
39 We imputed all SNPs in the HAPMAP
within the range of our data plus 20kb either side—
giving us 141 SNPs (110 imputed) for our case-control
analysis.
The output from IMPUTE gives probabilities for each
genotype, rather than point estimates. The use of
probabilities allowed us to account for the uncertainty
in imputation within the case-control analysis using
SNPTEST.
Pseudo case-control analysis using SNPTEST
For each affected child in the study, we created a
matched control using the untransmitted alleles from
their parents. As phasing the data was possible, we could
have matched each case to all haplotypes that could have
been passed on from the parents. However, this would
not have been possible for the imputed SNPs, therefore
we only matched to genotypes made up from the
untransmitted alleles.
The data were analyzed using classical methods,
which returned P-values. Logistic regression additive
models were fitted with SLE as the outcome.
We carried out a meta-analysis by combining the P-
values from the United Kingdom and Minnesota
parental-affected trios and the UK-independent pseudo
case-control study using Fisher’s method.
40
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